Cargando…

A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa

BACKGROUND: Analysis of hospital-acquired bloodstream infection (HA-BSI) trends is important to monitor emerging antimicrobial resistance (AMR) threats and guide empiric antibiotic choices. METHODS: A retrospective 10-year review of neonatal HA-BSI was performed at Tygerberg Hospital’s neonatal unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Kessendri, Bekker, Adrie, Whitelaw, Andrew C., Esterhuizen, Tonya M., Dramowski, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808607/
https://www.ncbi.nlm.nih.gov/pubmed/33444334
http://dx.doi.org/10.1371/journal.pone.0245089
_version_ 1783636935141490688
author Reddy, Kessendri
Bekker, Adrie
Whitelaw, Andrew C.
Esterhuizen, Tonya M.
Dramowski, Angela
author_facet Reddy, Kessendri
Bekker, Adrie
Whitelaw, Andrew C.
Esterhuizen, Tonya M.
Dramowski, Angela
author_sort Reddy, Kessendri
collection PubMed
description BACKGROUND: Analysis of hospital-acquired bloodstream infection (HA-BSI) trends is important to monitor emerging antimicrobial resistance (AMR) threats and guide empiric antibiotic choices. METHODS: A retrospective 10-year review of neonatal HA-BSI was performed at Tygerberg Hospital’s neonatal unit in Cape Town, South Africa. Neonatal clinical and laboratory data from 2014 to 2018 (Period 2) was compared with published data from 2009 to 2013 (Period 1). RESULTS: The neonatal unit’s HA-BSI rate declined between periods from 3.9/1000 inpatient-days in Period 1 to 3.3/1000 inpatient-days in Period 2 (p = 0.002). Pathogen yield and blood culture contamination rate were unchanged (11.0% to 10.4%, p = 0.233; 5.1% to 5.3%, p = 0.636 respectively). Gram-negative pathogens predominated (1047/1636; 64.0%); Klebsiella species, Staphylococcus aureus, Serratia marcescens, Enterococcus species and Acinetobacter baumannii were the most frequent pathogens. Extended spectrum beta-lactamase production was observed in 319/432 (73.8%) of Klebsiella species, methicillin resistance in 171/246 (69.5%) of Staphylococcus aureus and extensive drug resistance in 115/137 (83.9%) of Acinetobacter species (2009–2018). The crude mortality rate of neonatal HA-BSI episodes increased from Period 1 to Period 2 from 139/717 (19.4%) to 179/718 (24.9%) (p = 0.014), but HA-BSI attributable mortality remained unchanged (97/139 [69.8%] vs 118/179 [65.9%], p = 0.542). The in-vitro activity of piperacillin-tazobactam and amikacin declined during Period 2 (74.6% to 61.4%; p<0.001). CONCLUSION: Although HA-BSI rates declined in the neonatal unit, antimicrobial resistance rates in BSI pathogens remained high. Continuous BSI surveillance is a valuable tool to detect changes in pathogen and AMR profiles and inform empiric antibiotic recommendations for neonatal units in resource-limited settings.
format Online
Article
Text
id pubmed-7808607
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78086072021-02-02 A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa Reddy, Kessendri Bekker, Adrie Whitelaw, Andrew C. Esterhuizen, Tonya M. Dramowski, Angela PLoS One Research Article BACKGROUND: Analysis of hospital-acquired bloodstream infection (HA-BSI) trends is important to monitor emerging antimicrobial resistance (AMR) threats and guide empiric antibiotic choices. METHODS: A retrospective 10-year review of neonatal HA-BSI was performed at Tygerberg Hospital’s neonatal unit in Cape Town, South Africa. Neonatal clinical and laboratory data from 2014 to 2018 (Period 2) was compared with published data from 2009 to 2013 (Period 1). RESULTS: The neonatal unit’s HA-BSI rate declined between periods from 3.9/1000 inpatient-days in Period 1 to 3.3/1000 inpatient-days in Period 2 (p = 0.002). Pathogen yield and blood culture contamination rate were unchanged (11.0% to 10.4%, p = 0.233; 5.1% to 5.3%, p = 0.636 respectively). Gram-negative pathogens predominated (1047/1636; 64.0%); Klebsiella species, Staphylococcus aureus, Serratia marcescens, Enterococcus species and Acinetobacter baumannii were the most frequent pathogens. Extended spectrum beta-lactamase production was observed in 319/432 (73.8%) of Klebsiella species, methicillin resistance in 171/246 (69.5%) of Staphylococcus aureus and extensive drug resistance in 115/137 (83.9%) of Acinetobacter species (2009–2018). The crude mortality rate of neonatal HA-BSI episodes increased from Period 1 to Period 2 from 139/717 (19.4%) to 179/718 (24.9%) (p = 0.014), but HA-BSI attributable mortality remained unchanged (97/139 [69.8%] vs 118/179 [65.9%], p = 0.542). The in-vitro activity of piperacillin-tazobactam and amikacin declined during Period 2 (74.6% to 61.4%; p<0.001). CONCLUSION: Although HA-BSI rates declined in the neonatal unit, antimicrobial resistance rates in BSI pathogens remained high. Continuous BSI surveillance is a valuable tool to detect changes in pathogen and AMR profiles and inform empiric antibiotic recommendations for neonatal units in resource-limited settings. Public Library of Science 2021-01-14 /pmc/articles/PMC7808607/ /pubmed/33444334 http://dx.doi.org/10.1371/journal.pone.0245089 Text en © 2021 Reddy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Reddy, Kessendri
Bekker, Adrie
Whitelaw, Andrew C.
Esterhuizen, Tonya M.
Dramowski, Angela
A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title_full A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title_fullStr A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title_full_unstemmed A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title_short A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at Tygerberg Hospital, South Africa
title_sort retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009–2018 at tygerberg hospital, south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808607/
https://www.ncbi.nlm.nih.gov/pubmed/33444334
http://dx.doi.org/10.1371/journal.pone.0245089
work_keys_str_mv AT reddykessendri aretrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT bekkeradrie aretrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT whitelawandrewc aretrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT esterhuizentonyam aretrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT dramowskiangela aretrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT reddykessendri retrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT bekkeradrie retrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT whitelawandrewc retrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT esterhuizentonyam retrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica
AT dramowskiangela retrospectiveanalysisofpathogenprofileantimicrobialresistanceandmortalityinneonatalhospitalacquiredbloodstreaminfectionsfrom20092018attygerberghospitalsouthafrica